Compared to Estimates, Linde (LIN) Q1 Earnings: A Look at Key Metrics

01.05.25 15:30 Uhr

Werte in diesem Artikel
Aktien

402,40 EUR 2,40 EUR 0,60%

Indizes

PKT PKT

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

129,0 PKT 2,7 PKT 2,10%

552,9 PKT 11,4 PKT 2,11%

12.053,0 PKT 293,0 PKT 2,49%

20.102,6 PKT 315,9 PKT 1,60%

8.920,7 PKT 223,1 PKT 2,56%

2.756,5 PKT 37,3 PKT 1,37%

5.686,7 PKT 82,5 PKT 1,47%

23.111,9 PKT 467,2 PKT 2,06%

Linde (LIN) reported $8.11 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 0.2%. EPS of $3.95 for the same period compares to $3.75 a year ago.The reported revenue represents a surprise of -1.77% over the Zacks Consensus Estimate of $8.26 billion. With the consensus EPS estimate being $3.93, the EPS surprise was +0.51%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Linde performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Sales- Americas: $3.67 billion compared to the $3.73 billion average estimate based on three analysts. The reported number represents a change of +3% year over year. Sales- EMEA: $2.03 billion versus $2.14 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -2.9% change. Sales- Other: $311 million compared to the $319.40 million average estimate based on three analysts. The reported number represents a change of -2.5% year over year. Sales- Engineering: $565 million versus $571.95 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +4.8% change. Sales- APAC: $1.54 billion versus the three-analyst average estimate of $1.57 billion. The reported number represents a year-over-year change of -3.3%. View all Key Company Metrics for Linde here>>>Shares of Linde have returned -3.5% over the past month versus the Zacks S&P 500 composite's -0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Linde PLC (LIN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Linde

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Linde

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Linde plc

Wer­bung

Analysen zu Linde plc

DatumRatingAnalyst
02.05.2025Linde BuyJefferies & Company Inc.
01.05.2025Linde NeutralUBS AG
10.04.2025Linde OutperformBernstein Research
09.04.2025Linde OutperformBernstein Research
04.04.2025Linde OutperformBernstein Research
DatumRatingAnalyst
02.05.2025Linde BuyJefferies & Company Inc.
10.04.2025Linde OutperformBernstein Research
09.04.2025Linde OutperformBernstein Research
04.04.2025Linde OutperformBernstein Research
03.04.2025Linde BuyJefferies & Company Inc.
DatumRatingAnalyst
01.05.2025Linde NeutralUBS AG
12.03.2025Linde NeutralUBS AG
06.02.2025Linde NeutralUBS AG
09.12.2024Linde NeutralUBS AG
31.10.2024Linde NeutralUBS AG
DatumRatingAnalyst
07.02.2023Linde ReduceBaader Bank
19.01.2023Linde ReduceBaader Bank
27.10.2022Linde ReduceBaader Bank
25.10.2022Linde ReduceBaader Bank
18.10.2022Linde ReduceBaader Bank

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Linde plc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen